Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial
Nat Rev Immunol
.
2012 Oct;12(10):740; author reply 740.
doi: 10.1038/nri3192-c1.
Epub 2012 Aug 31.
Authors
Christopher Horvath
,
Laura Andrews
,
Andreas Baumann
,
Lauren Black
,
Diann Blanset
,
Joy Cavagnaro
,
Kenneth L Hastings
,
David L Hutto
,
Timothy K MacLachlan
,
Mark Milton
,
Theresa Reynolds
,
Stan Roberts
,
Mark Rogge
,
Jennifer Sims
,
George Treacy
,
Garvin Warner
,
James D Green
PMID:
22941443
DOI:
10.1038/nri3192-c1
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Antibodies, Monoclonal, Humanized / therapeutic use*
Clinical Trials as Topic*
Humans
Male
Substances
Antibodies, Monoclonal, Humanized